This invention relates to compounds of the Formula (I): ##STR00001## or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, TNF-.alpha. or combinations thereof.

 
Web www.patentalert.com

< Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers

> Phenanthroindolizidine alkaloids

> Cyclic ureas used as inhibitors of metalloproteases
~ 00577